Addisonian Crisis Precipitated by Thyroxine Therapy: A Complication of Type 2 Autoimmune Polyglandular Syndrome

Southern Medical Journal

Volumn 96, Issue 8, 2003, Pages 824-827

  Graves III, Leland ^a   Klein, Robert M ^b   Walling, Anne D ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; LEVOTHYROXINE; MICROSOME ANTIBODY; THYROXINE; ANTI THYROGLOBULIN; ANTI-THYROGLOBULIN; AUTOANTIBODY; AUTOANTIGEN; CORTICOTROPIN; DIAGNOSTIC AGENT; IODIDE PEROXIDASE; IRON BINDING PROTEIN; THYROTROPIN; TPO PROTEIN, HUMAN;

ADRENAL CORTEX INSUFFICIENCY; ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; AUTOIMMUNITY; CASE REPORT; CLINICAL FEATURE; FEMALE; HORMONAL THERAPY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHYROIDISM; LABORATORY TEST; PHYSICAL EXAMINATION; ADDISON DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY; B LYMPHOCYTE; BLOOD; DIFFERENTIAL DIAGNOSIS; DRUG MONITORING; EPIDEMIOLOGY; HORMONE SUBSTITUTION; IMMUNOLOGY; MALE; METHODOLOGY; T LYMPHOCYTE; WEIGHT REDUCTION;

ADDISON DISEASE; ADRENOCORTICOTROPIC HORMONE; ADULT; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; DIAGNOSIS, DIFFERENTIAL; DRUG MONITORING; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; HYPOTHYROIDISM; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE; PRECIPITATING FACTORS; T-LYMPHOCYTES; THYROTROPIN; THYROXINE; WEIGHT LOSS;

EID: 0142009597     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000056647.58668.CD     Document Type: Article

References (13)

1. Schmidt MB. Eine biglanduloma Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 1926;21:212-221.
2. Graber MA, Freed HA. Polyglandular autoimmune syndrome: A cause of multiple and sequential endocrine emergencies. Am J Emerg Med 1992;10:130-132.
3. Betterle C, Dal Pra C, Greggio N, et al. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2, and 4. Ann Endocrinol 2001;62:193-201.
4. Riley WJ. Autoimmune polyglandular syndromes. Horm Res 1992;38: 9-15.
5. Khalil S, Evers ML. Case report: Autoimmune polyglandular syndrome. N J Med 1995;92:671-674.
6. Neufeld M, Blizzard RM. Polyglandular autoimmune diseases, in Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds): Symposium on Autoimmune Aspects of Endocrine Disorders. New York, Academic Press, 1980, pp 357-365.
7. Vaidya B, Pearce S, Kendall-Taylor P. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure. Clin Endocrinol 2000;53:403-418.
8. Peterson P, Uibo R, Krohn KJ. Adrenal autoimmunity: Results and developments. Trends Endocrinol Metab 2000;11:285-290.
9. Muir A, Maclaren NK. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads and hypothalamic-pituitary axis. Endocrinol Metab Clin North Am 1991;20:619-645.
10. Werbel SS, Ober KP. Acute adrenal insufficiency. Endocrinol Metab Clin North Am 1993;22:303-328.
11. Davenport J, Kellerman C, Reiss D, et al. Addison's disease. Am Fam Physician 1991;43:1338-1342.
12. Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J Autoimmun 1995;8:121-130.
13. Chung AD, English JC. Cutaneous hyperpigmentation and polyglandular autoimmune syndrome type II. Cutis 1997;59:77-80.